logo
  • Home
  • About Us
    • About Us
    • Why Raglan
    • Careers
  • Selected Transactions
  • Raglan IPO Projects
    • Raglan Pharmaceutical & Life Science Projects
    • Raglan Natural Resources
  • News
  • Contact us
  • Search
Open Orphan starts trials on nasal spray COVID-19 vaccines
  1. Home
  2. 2021
  3. Open Orphan starts trials on nasal spray COVID-19 vaccines

Recent News

  • World’s first trial of deliberate coronavirus infection is approved
  • Scientists win approval to infect healthy volunteers with Covid for trial
  • Open Orphan gets final go-ahead for Covid-19 human trial
  • Covid-19: World’s first human challenge trials to start in UK
  • COVID-19: Volunteers to be exposed to virus in world-first study in UK
  • Open Orphan starts trials on nasal spray COVID-19 vaccines
  • Prev
  • Next
Join us for our newsletters
Loading

Raglan Capital
18 Fitzwilliam Place, Dublin 2.
T: +353 1 6440007
E: info@raglancapital.ie

  • Contact us
  • Careers
  • Privacy Policy
  • Cookie policy (EU)
Join us for our newsletters
Loading

Raglan Capital
18 Fitzwilliam Place, Dublin 2.
T: +353 1 6440007
E: info@raglancapital.ie

  • Contact us
  • Careers
  • Privacy Policy
  • Cookie policy (EU)
© 2021 Raglan Capital. All rights reserved

Privacy Preference Center

Privacy Preferences